{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:05:23Z","timestamp":1765609523215},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.jcv.2011.12.010","type":"journal-article","created":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T20:17:34Z","timestamp":1326917854000},"page":"201-207","source":"Crossref","is-referenced-by-count":15,"title":["Comparison of a commercial Varicella Zoster glycoprotein IgG enzyme immunoassay with a reference time resolved fluorescence immunoassay (VZV TRFIA) for measuring VZV IgG in sera from pregnant women, sera sent for confirmatory testing and pre and post vOka vaccination sera from healthcare workers"],"prefix":"10.1016","volume":"53","author":[{"given":"P.A.C.","family":"Maple","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Quinlivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kafatos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2011.12.010_bib0005","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/CMR.9.3.361","article-title":"Varicella-Zoster virus","volume":"9","author":"Arvin","year":"1996","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jcv.2011.12.010_bib0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jinf.2008.03.004","article-title":"British Infection Society. Chickenpox in adults \u2013 clinical management","volume":"57","author":"Tunbridge","year":"2008","journal-title":"J Infect"},{"key":"10.1016\/j.jcv.2011.12.010_bib0015","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bmj.323.7321.1091","article-title":"Deaths from chickenpox in England and Wales 1995\u20137: analysis of routine mortality data","volume":"323","author":"Rawson","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.jcv.2011.12.010_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1479-828X.2007.00797.x","article-title":"Varicella and the pregnant woman: prevention and management","volume":"48","author":"Daley","year":"2008","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.jcv.2011.12.010_bib0025","series-title":"Immunisation against infectious disease","author":"Joint Committee of Vaccination and Immunisation","year":"2006"},{"key":"10.1016\/j.jcv.2011.12.010_bib0030","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0264-410X(92)90109-W","article-title":"Current status and prospects of live varicella vaccine","volume":"10","author":"Takahashi","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2011.12.010_bib0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/CMR.00031-09","article-title":"Impact of varicella vaccine on Varicella-Zoster virus dynamics","volume":"23","author":"Schmid","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jcv.2011.12.010_bib0040","first-page":"43","article-title":"Varicella zoster virus vaccination policies and surveillance strategies in Europe","volume":"10","author":"Pinot de Moira","year":"2000","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jcv.2011.12.010_bib0045","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJM200103293441310","article-title":"Varicella vaccine \u2013 the first six years","volume":"344","author":"Arvin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcv.2011.12.010_bib0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jmv.1890250207","article-title":"Natural and artificial immunity to Varicella Zoster virus","volume":"25","author":"Ndumbe","year":"1988","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcv.2011.12.010_bib0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0264-410X(91)90266-9","article-title":"Antibody assays suitable for assessing immune responses to live varicella vaccine","volume":"9","author":"Provost","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2011.12.010_bib0060","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/CVI.13.2.214-218.2006","article-title":"Performance of a time-resolved fluorescence immunoassay for measuring Varicella-Zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay","volume":"13","author":"Maple","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jcv.2011.12.010_bib0065","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jviromet.2008.12.007","article-title":"Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection","volume":"157","author":"Chris Maple","year":"2009","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jcv.2011.12.010_bib0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcv.2008.08.012","article-title":"Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assay","volume":"44","author":"Maple","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2011.12.010_bib0075","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s10096-011-1211-4","article-title":"Follow-up of pregnant women exposed to chicken pox: an audit of relationship between level of antibody and development of chicken pox","volume":"30","author":"Boxall","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jcv.2011.12.010_bib0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jviromet.2010.12.021","article-title":"Evaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workers","volume":"172","author":"McDonald","year":"2011","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jcv.2011.12.010_bib0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jviromet.2008.09.032","article-title":"Comparison of fifteen commercial assays for detecting varicella zoster virus IgG with reference to a time resolved fluorescence immunoassay (TRFIA) and the performance of two commercial assays for screening sera from immunocompromised individuals","volume":"155","author":"Chris Maple","year":"2009","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jcv.2011.12.010_bib0090","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1128\/JCM.00719-06","article-title":"Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen","volume":"44","author":"Sauerbrei","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2011.12.010_bib0095","first-page":"1","article-title":"Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen","volume":"55","author":"Sauerbrei","year":"2009","journal-title":"Clin Lab"},{"issue":"Suppl. 2","key":"10.1016\/j.jcv.2011.12.010_bib0100","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1086\/529448","article-title":"Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccines and to screen for susceptibility to varicella","volume":"197","author":"Breuer","year":"2008","journal-title":"JID"},{"key":"10.1016\/j.jcv.2011.12.010_bib0105","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0891-5520(05)70311-1","article-title":"Assays for antibodies to varicella-zoster virus","volume":"10","author":"Krah","year":"1996","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jcv.2011.12.010_bib0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jmv.1890320310","article-title":"Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen","volume":"32","author":"Wasmuth","year":"1990","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcv.2011.12.010_bib0115","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/jmv.20754","article-title":"The optimization and validation of the glycoprotein ELISA assay for quantitative Varicella-Zoster virus (VZV) antibody detection","volume":"78","author":"Hammond","year":"2006","journal-title":"J Med Virol"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653211005178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653211005178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T17:09:15Z","timestamp":1561223355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653211005178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1386653211005178"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2011.12.010","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}